Header cover image

U.S. Biotech Breakthroughs

UPDATED Apr 19, 2024

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

54 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BOVN.F

BioInvent International		kr4.700%n/akr2.7bkr12.58PS9.2xE62.0%n/a

RCEL

AVITA Medical		US$8.64-12.6%-39.6%US$222.9mUS$26.06PS4.4xE62.9%n/a

GTHX

G1 Therapeutics		US$4.11-9.7%52.2%US$214.5mUS$8.50PS2.6xE55.1%n/a

SGEN

Seagen		US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

IMGN

ImmunoGen		US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

IPHY.F

Innate Pharma		€2.650%n/a€173.8m€7.73PS2.8xE33.0%n/a

AVHH.L

AVITA Medical		US$2.10-34.4%-22.2%US$228.8mUS$6.34PS4.4xE62.9%n/a

ARDX

Ardelyx		US$6.48-8.2%30.9%US$1.5bUS$13.50PS12.1xE59.6%n/a

IPHA

Innate Pharma		€2.44-1.6%-18.4%€170.6m€7.25PS2.8xE33.0%n/a

ISEE

IVERIC bio		US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

CAPR

Capricor Therapeutics		US$5.01-19.8%21.6%US$157.8mUS$21.00PS6.3xE59.4%n/a

ABEO

Abeona Therapeutics		US$7.570.3%135.1%US$207.1mUS$21.00PS59.2xE60.7%n/a

MDGL

Madrigal Pharmaceuticals		US$212.04-10.4%-30.1%US$4.5bUS$394.54PB11xE62.2%n/a

SPRY

ARS Pharmaceuticals		US$8.47-6.1%29.5%US$817.4mUS$19.00PS27245.6xE56.2%n/a

ACAD

ACADIA Pharmaceuticals		US$16.82-1.9%-16.3%US$2.8bUS$29.06PS3.8xE40.8%n/a

MGTX

MeiraGTx Holdings		US$5.09-8.5%-10.2%US$326.9mUS$21.60PS23.3xE52.8%n/a

SRPT

Sarepta Therapeutics		US$115.62-5.9%-9.7%US$10.9bUS$164.54PS8.7xE42.7%n/a

PRRU.F

Immutep		AU$0.240%n/aAU$422.0mn/aPS107.4xE60.3%n/a

MEOB.F

Mesoblast		AU$0.600%n/aAU$884.5mn/aPS76.1xE64.4%n/a

PGEN

Precigen		US$1.33-6.3%9.0%US$331.1mUS$9.00PS53.2xE55.5%n/a

GNFT

Genfit		€3.41-4.8%-9.3%€157.1m€10.12PS4.6xE54.7%n/a

ARGX

argenx		€360.23-4.7%-7.5%€20.0b€469.25PS16.8xE56.1%n/a

SBFM

Sunshine Biopharma		US$1.77-78.0%-97.4%US$1.8mUS$300.00PB0.08xE134.4%n/a

KRTX

Karuna Therapeutics		US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a
Page 1 of 3
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.